Clinical Trials Browser

Phase 1/2 × Esophageal Neoplasms × donafenib × Clear all

NCT02489201 2023-06-15

A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer

Phase 1/2 Terminated

Gastrointestinal

Esophageal Neoplasms